Monday 16 July 2018

Isosorbide Market Size Expected To Be Worth $703.1 Million By 2025

The global isosorbide market is projected to reach a valuation of USD 703.1 million by 2025, according to a report by Grand View Research, Inc. Isosorbide is a chemical compound primarily derived from glucose. The naturally-derived compound has applications in pharmaceuticals, solvents, monomers, and plasticizers. Derivatives of the compound used in various industrial sectors are isosorbide esters, isosorbide based polyurethane, isosorbide polycarbonate resins, and isosorbide diglicidyl.
The isosorbide market is anticipated to expand at a 10.9% CAGR from 2016 to 2025. It had registered over 32 kilotons in 2015. The increasing demand to replace fossil fuel-based derivatives with natural derivatives is expected to drive market growth over the forecast period (2014 to 2025). Demand for bio-polyethylene isosorbide terephthalate (PEIT) in Asia Pacific is predicted to positively impact market. Stringent regulations by environmental agencies are expected to fuel the demand for bio-based chemicals over the forecast period.

To request a sample copy or view summary of this report, click the link below: https://www.grandviewresearch.com/industry-analysis/isosorbide-industry

The potential to remove bisphenol-A (BPA) from polycarbonates and to replace it with isosorbide alternatives has garnered the interest of chemical manufacturers. Roquette Frères has combined PEIT with its proprietary POLYSORB isosorbide to create temperature-resistant polyesters. Manufacturers are leaning towards natural compounds to act as a feedstock to produce plastic parts. For instance, Mazda Corporation collaborated with Mitsubishi Chemical Corporation to create bio-based plastics derived from isosorbide in December 2017. The use of the compound in pharmaceuticals is projected to open up new avenues for growth.

The global isosorbide market is fragmented by application, end-use, and region. Major applications include polyurethane, polycarbonate, polyester polyisosorbide succinate, polyethylene isosorbide terephthalate (PEIT), isosorbide esters, and others. End-use segments include additives, resins and polymers, and others.

On the basis of regions, the market is divided into North America, Central and South America (CSA), Asia Pacific (APAC), Europe, and Middle East and Africa (MEA). The APAC market accounted for over 34% market share, in terms of volume, in 2015 due to demand for bioplastics from China. This can be credited to low labor and material costs in China. The satisfactory results of isosorbides in polymers have led to its adoption by several companies as a monomer or additive.

The North America market is expected to exhibit a 10.9% CAGR from 2016 to 2025 owing to technological breakthroughs in isosorbide production processes and rising demand for bio-based products from the region. The shale gas industry is expected to benefit the most in the region due to high raw feedstock prices of isoprene and butadiene. In addition, the success of hydralazine–isosorbide dinitrate (H-ISDN) to treat congestive heart failure in African-Americans may positively impact the overall demand. The CSA market is predicted to expand at a 10.4% CAGR over the forecast period. Favorable government policies to produce automobile components from bio-based polymers are expected to bode well for the isosorbide market in this region.

The European market was valued at over USD 77 million in 2015 due to favorable regulations in the region. In addition, the high demand for bulk chemicals such as lactic acid, propylene glycol, and ethylene glycol is expected to influence regional demand. The MEA market is expected a steady growth rate over the forecast period due to high incidence of angina in the Middle East and South Africa. Isosorbide is an one of the indispensable components in drugs necessary to treat acute heart failure (AHF) and coronary heart disease (CHD). The Gulf CARE registry is a centralized database that records the effects of isosorbide in heart disorder patients. This will be instrumental in improving the outcomes of patients and provide insights to pharmaceutical companies to improve their existing products.

Key players operating in the worldwide isosorbide market include Cargill, Incorporated; Roquette Frères; J P Laboratories Pvt. Ltd.; Novaphene Specialities Private Limited; and Par Pharmaceutical. Expansions and research of novel technologies are strategies followed by most players to sustain their position in the market. For instance, Roquette has opened new manufacturing bases in China, India, and Thailand to stabilize production costs. Most market participants have shifted their focus towards developing bio-based compounds. Recent studies have shown the success of dental implants derived from isosorbide monomers. They could be a viable replacement for bisphenol A glycerolate dimethacrylate (Bis-GMA) based materials.

Access Press Release Of This Research Report by Grand View Research: https://www.grandviewresearch.com/press-release/isosorbide-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com


No comments:

Post a Comment